First posted April 19, 2021; last updated June 27, 2023
National Library of Medicine
Pfizer, Inc. and Kaiser Permanente Southern California
“Estimated Study Completion Date: December 30, 2023”
document
clinical trials,COVID-19,FDA approvals,manufacturers,vaccines